✦ LIBER ✦

Pharmacodynamics, Pharmacokinetics, and Tolerability of Intravenous or Subcutaneous GC1113, a Novel Erythropoiesis-Stimulating Agent

✍ Scribed by Han, HyeKyung; Lee, Jongtae; Shin, Donghoon; Shin, Kwang-Hee; Jeon, Hyewon; Lim, Kyoung Soo; Yoon, Seo Hyun; Shin, Sang-Goo; Jang, In-Jin; Cho, Joo-Youn; Yu, Kyung-Sang

Book ID: 125386759
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 657 KB
Volume: 34
Category: Article
ISSN: 1179-1918
DOI: 10.1007/s40261-014-0183-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of CTLA4Ig (BMS-188667), a Novel Immunosuppressive Agent, After Subcutaneous and Intravenous Administration to Mice

✍ NUGGEHALLY R. SRINIVAS; RUSSELL S. WEINER; KAREN BERRY; LEE K. TAY; WEN CHYI SHY 📂 Article 📅 1998 🏛 Pharmaceutical Press 🌐 English ⚖ 554 KB

Safety, tolerability, pharmacokinetics a

Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers

✍ Barbour, April M.; Sarov-Blat, Lea; Cai, Gengqian; Fossler, Michael J.; Sprecher 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

Pharmacokinetics of CTLA4Ig (BMS-188667)

Pharmacokinetics of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following intravenous and subcutaneous administration to mice

✍ N. R. Srinivas; W. C. Shyu; D. S. Greene; R. H. Barbhaiya; R. S. Weiner; L. K. T 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Interferon Beta-la (IFNβ-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration

✍ Dr John Alam, Arthur McAllister, James Scaramucci, Wendy Jones, Mark Rogge 📂 Article 📅 1997 🏛 Springer International Publishing AG 🌐 English ⚖ 149 KB

Pharmacokinetics, Pharmacodynamics, Safe

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects

✍ Katz, L B; Gambale, J J; Rothenberg, P L; Vanapalli, S R; Vaccaro, N; Xi, L; Pol 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

An assessment of the pharmacokinetics, p

An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects

✍ Shin, Kwang-Hee; Lim, Kyoung Soo; Lee, Howard; Jang, In-Jin; Yu, Kyung-Sang 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 293 KB